These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 546656)

  • 21. Primary resistance to the major drugs in tuberculous patients, in 1961-1966.
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Pol Med J; 1969; 8(5):1131-5. PubMed ID: 4986628
    [No Abstract]   [Full Text] [Related]  

  • 22. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. II. Antituberculosis activity of INH and SM in vitro after exposure to PAS.
    Maekawa N; Nakanishi ; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Aug; 46(8):293-4. PubMed ID: 4998861
    [No Abstract]   [Full Text] [Related]  

  • 25. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 26. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.
    MCCUNE RM; TOMPSETT R
    J Exp Med; 1956 Nov; 104(5):737-62. PubMed ID: 13367341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistant tubercle bacilli.
    Lancet; 1972 Aug; 2(7774):412-3. PubMed ID: 4115230
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tuberculosis by microcultivation on slides in blood medium].
    Smirnov VD
    Antibiotiki; 1971; 16(8):738-40. PubMed ID: 5003152
    [No Abstract]   [Full Text] [Related]  

  • 30. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary drug resistance of Mycobacterium tuberculosis isolated from untreated patients with pulmonary tuberculosis in Korea].
    Kim SC
    Kekkaku; 1971 May; 46(5):165-71. PubMed ID: 4996121
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary resistance to INH, PAS and STM. Significance of individual mycobacterial strains for newly diagnosed cases of pulmonary tuberculosis in the middle Bohemia region in 1967 and 1972 (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1974 Nov; 113(46):1419-22. PubMed ID: 4216401
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversion to drug sensitivity in tubercle bacilli.
    Stewart SM
    Tubercle; 1966 Jun; 47(2):190-7. PubMed ID: 4960413
    [No Abstract]   [Full Text] [Related]  

  • 34. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 35. [Occurrence and clinical importance of drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis].
    Kuznetsova EE
    Probl Tuberk; 1970; 48(9):39-43. PubMed ID: 4996495
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
    Kalich R; Nitschke M; Ulber H; Mydlak G; Werner E; Gerloff W; Reinhold L
    Z Erkr Atmungsorgane; 1974; 140(3):242-52. PubMed ID: 4142152
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. I. Incubating temperature and chemotherapeutic effect].
    Maekawa N; Nakanishi M; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Jul; 46(7):235-7. PubMed ID: 5000367
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.